A commonly used cholesterol drug, statins, is showing promise beyond heart health, offering new hope for people battling Alzheimer’s disease.
Studies suggest that statins may help reduce the risk of cognitive decline and slow the progression of Alzheimer's by supporting brain health.
Statins are believed to help break down amyloid plaques, a hallmark of Alzheimer's, potentially reducing damage to brain cells.
Because statins are already approved for cholesterol management, they come with a known safety profile, offering less risk to patients than entirely new treatments.
Early clinical trials have shown promising results, with some patients experiencing slowed memory decline after taking statins, fueling further research.
Statins are widely available and relatively inexpensive compared to newer Alzheimer’s medications, making them a more accessible option for many patients.
If proven effective, statins could be used by millions of Alzheimer’s patients worldwide, offering a new avenue for treatment in the battle against the disease.